Across TCGA pan-cancer cohorts, BRAFP1 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of BRAFP1’s most consistent transcriptional readouts.

The strongest signal is observed in esophageal carcinoma (ESCA), where BRAFP1 RNA is repressed in tumor relative to normal tissue. In most cancer types BRAFP1 is over-expressed in tumor, although a few such as ESCA and THCA show the opposite, repressed pattern.

ESCA, THCA, and CHOL are the cancer types where BRAFP1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BRAFP1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
ESCA	Female	All	−0.053	.021	1	view →
THCA	Female	All	−0.037	.011	1	view →
CHOL	All	All	+0.025	.047	1	view →
LIHC	All	II,III,IV	+0.013	.034	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: BRAFP1 RNA expression & survival · all BRAFP1 data types